Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
96,511,448
-
Shares change
-
+2,643,827
-
Total reported value, excl. options
-
$91,887,186
-
Value change
-
+$2,277,396
-
Put/Call ratio
-
40%
-
Number of buys
-
57
-
Number of sells
-
55
-
Price
-
$0.9521
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2023
As of 31 Dec 2023 CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) had 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 96,511,448 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PNC FINANCIAL SERVICES GROUP, INC., GEODE CAPITAL MANAGEMENT, LLC, JUPITER ASSET MANAGEMENT LTD, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, D. E. Shaw & Co., Inc., and Qube Research & Technologies Ltd.
This table shows 142 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.